top of page

A radiation-free early breast cancer detection using only a single blood sample.

At earlytrace, we are developing an early breast cancer detection solution that leverages advanced AI and blood biomarkers analysis.

image.png

Impact of early breast cancer detection solution

1 in 8

Breast cancer diagnosis in a women’s lifetime¹

39%

Combined Breast cancer screening deficit in Europe. EE at 51%²

36%

# mortality reduction with early screening availability per year.³

Our Solution

Screening for breast cancer

with a blood sample.

Pipetting Samples

Innovative Proteomics Approach

Our cutting-edge solution leverages specific protein biomarkers to analyse protein patterns in blood samples, identifying early signs of breast cancer.

Detecting cancer-specific proteins in the patient's blood combined with AI, our solution enables early intervention, increasing the chances of successful treatment.

Simple, Non-Invasive Process

​​Our radiation-free AI-powered analysis, using just a blood sample, provides highly accurate predictions of breast cancer sensitivity. 

Early Intervention

The entire analysis process aims to take 2 weeks, from the arrival of the blood sample at the specialised earlytrace laboratory to the availability of the result.​​

Latest Articles

Meet our Team

We are a diverse team united by a shared passion for advancing digital innovation in cancer detection. Our commitment is to be at the forefront of new technologies to transform patient outcomes and improve lives.

Dr. Nicole Schneiderhan-Marra

20+ years experience in biomarker research and bioanalytical test development, providing services for pharma and academics and group/ department management.

  • LinkedIn
Marc.png
Marc Mausch

20+ years of technology business experience across several industries, and successfully founded and established a Telemed company.

  • LinkedIn
Dr.Jens Göpfert

15+ years of experience in biomarker research and ultrasensitive immunoassay development, providing GCP-compliant analysis of clinical trial samples to pharmaceutical companies, and project and group management.

  • LinkedIn
2022_05_11_NMI_Goepfert_Jens-2.jpg
WhatsApp Image 2024-09-01 at 14.04.46.jpeg
Sofiane Ouaari

5+ years of experience developing Machine Learning applications and Data Analytics solutions in various domains, including FinTech, NLP/NLG and Healthcare.

  • LinkedIn
Ifeoma Wulz

​​

Ex-founder with 15 years of experience in growth marketing and commercialisation across several industries, from Tech to global cooperations.

  • LinkedIn

References

1- for Europe only source: Institutional agency for research cancer (WHO). https://gco.iarc.fr/today/en/dataviz/maps-heatmap?mode=population&cancers=20&zoom=5

2- Europe only. EE is leading with 51%, and SE = 31%. Int J Cancer. 2021 Jan 15; 148(2): 406–418. Published online 2020 Jul 30. doi: 10.1002/ijc.3320 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754503/

3- Europe only with 100% coverage, 12 434 additional breast cancer deaths could be prevented annually. source: PubMed- www.ncbi.nlm.nih

Contact us

contact[at]earlytrace.com

bottom of page